Press Release Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024 29 May 2024
Press Release FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma 29 May 2024
Press Release SoSafe Announces New Executive Advisors as Company Expands Category and Product Leadership 29 May 2024
Press Release Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024 29 May 2024
Press Release VUZE Medical Announces U.S. FDA 510(K) Clearance for Second-Generation Software-Based 3D Guidance System for Spine Surgery 29 May 2024
